These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9950442)

  • 1. Differences between asthma exacerbations and poor asthma control.
    Reddel H; Ware S; Marks G; Salome C; Jenkins C; Woolcock A
    Lancet; 1999 Jan; 353(9150):364-9. PubMed ID: 9950442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which index of peak expiratory flow is most useful in the management of stable asthma?
    Reddel HK; Salome CM; Peat JK; Woolcock AJ
    Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing.
    Prieto L; Gutiérrez V; Morales C; Perpiñan J; Inchaurraga I
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.
    Tattersfield AE; Postma DS; Barnes PJ; Svensson K; Bauer CA; O'Byrne PM; Löfdahl CG; Pauwels RA; Ullman A
    Am J Respir Crit Care Med; 1999 Aug; 160(2):594-9. PubMed ID: 10430734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control.
    Saito J; Gibeon D; Macedo P; Menzies-Gow A; Bhavsar PK; Chung KF
    Eur Respir J; 2014 Feb; 43(2):474-84. PubMed ID: 23949962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variation of PEF and its use in epidemiological studies.
    Lebowitz MD; Krzyzanowski M; Quackenboss JJ; O'Rourke MK
    Eur Respir J Suppl; 1997 Feb; 24():49S-56S. PubMed ID: 9098711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
    Watanabe N; Makino S; Kihara N; Fukuda T
    Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronopharmacology and chronotherapy for asthma by using PEF].
    Burioka N; Sasaki T
    Nihon Rinsho; 1996 Nov; 54(11):2956-61. PubMed ID: 8950937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma.
    Chan-Yeung M; Chang JH; Manfreda J; Ferguson A; Becker A
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):889-93. PubMed ID: 8887581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group.
    Brand PL; Postma DS; Kerstjens HA; Koëter GH
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):916-21. PubMed ID: 2024843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness and early detection of acute exacerbation by peak expiratory flow rate in the management of asthma].
    Iwasaki Y; Kubota Y; Yokomura I; Ueda M; Hashimoto S; Mizobuchi K; Arimoto T; Hara H; Nakagawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Oct; 35(10):1040-6. PubMed ID: 9465613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of lung function predicts loss of asthma control following withdrawal of inhaled corticosteroid treatment.
    Thamrin C; Taylor DR; Jones SL; Suki B; Frey U
    Thorax; 2010 May; 65(5):403-8. PubMed ID: 20435861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
    Weersink EJ; van Zomeren EH; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1144-50. PubMed ID: 9351614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E; Gencer M; Aksoy S
    Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.
    Zimmerman B; D'Urzo A; Bérubé D
    Pediatr Pulmonol; 2004 Feb; 37(2):122-7. PubMed ID: 14730657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When can personal best peak flow be determined for asthma action plans?
    Reddel HK; Marks GB; Jenkins CR
    Thorax; 2004 Nov; 59(11):922-4. PubMed ID: 15516464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythm in peak expiratory flow: alteration with nocturnal asthma and theophylline chronotherapy.
    Burioka N; Suyama H; Sako T; Shimizu E
    Chronobiol Int; 2000 Jul; 17(4):513-9. PubMed ID: 10908127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LA phonospirometry technique compared to pediatric respiratory assessment measure and peak expiratory flow measurement as a novel technique to assess the severity of an asthma exacerbation.
    Ochoa K; Richman J; Wang VJ
    J Asthma; 2019 Sep; 56(9):959-963. PubMed ID: 30207809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.